Our research showed that miR-103-3p may inhibit ALT and AST to improve inflammation, decrease ROS and H2O2 levels to improve oxidative stress, and increase ATP levels to alleviate NAFLD damage by targeting ACOX1. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.